GlobeStar Therapeutics
GSTC · OTC
About GSTC
- Employees
- 0
- Headquarters
- Richland, Washington
- Listed
- May 21, 2011
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- globestarthera.com
GSTC key statistics
- Market cap
- 1.24K
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 564.58K
- Volume
- 15.00K
- Open price
- $0.00
- High today
- $0.00
- Low today
- $0.00
- 52 Week high
- $0.0001
- 52 Week low
- $0.00
GlobeStar Therapeutics (GSTC) at a glance
GlobeStar Therapeutics (GSTC) last traded at $0.00, with a market cap of 1.24K.
Volume so far is 15.00K shares, below the average of 564.58K shares a day.
Over the past year GlobeStar Therapeutics has ranged from $0.00 to $0.0001, and now sits 0% of the way up that range.
Similar companies
Companies in the same industry as GlobeStar Therapeutics
Most active stocks
Highest trading volume today
- SHFSSHF Holdings$0.0899−4.36%
- WHLRWheeler Real Estate Investment Trust$0.3597+2.19%
- RBNERobin Energy$0.3978−23.65%
- SDSTStardust Power$0.02−23.66%
- RCTRedCloud Holdings$0.084+1.94%
- WFFWF Holding$0.0929−3.83%
- NWGLCL Workshop Group$0.1522+27.90%
- DKIDarkiris$0.0479−6.08%
- AHTAshford Hospitality Trust$1.79−2.72%
- KORUDirexion Shares ETF Trust$11.34−4.87%
- SOXLDirexion Shares ETF Trust$97.55−1.12%
- SPCXSpace Exploration Technologies$147.79−0.11%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.